PAP

Persistent Asset Partners Portfolio holdings

AUM $114M
This Quarter Return
+9.54%
1 Year Return
3 Year Return
5 Year Return
10 Year Return
AUM
$114M
AUM Growth
+$114M
Cap. Flow
-$2.62M
Cap. Flow %
-2.3%
Top 10 Hldgs %
34.23%
Holding
207
New
51
Increased
27
Reduced
32
Closed
45

Sector Composition

1 Healthcare 61.17%
2 Financials 18.93%
3 Materials 5.9%
4 Technology 3.43%
5 Energy 2.34%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ARVN icon
101
Arvinas
ARVN
$580M
$164K 0.12%
+22,233
New +$164K
ESQ icon
102
Esquire Financial Holdings
ESQ
$814M
$157K 0.12%
1,656
-1,352
-45% -$128K
APGE icon
103
Apogee Therapeutics
APGE
$2.27B
$105K 0.08%
2,425
-6,753
-74% -$293K
PHAT icon
104
Phathom Pharmaceuticals
PHAT
$843M
$90.3K 0.07%
+9,421
New +$90.3K
AVR
105
Anteris Technologies Global Corp. Common Stock
AVR
$148M
$88.4K 0.07%
23,317
NUVL icon
106
Nuvalent
NUVL
$5.74B
$87.7K 0.07%
+1,150
New +$87.7K
ALEC icon
107
Alector
ALEC
$282M
$85.5K 0.06%
61,096
-43,831
-42% -$61.4K
PRQR icon
108
ProQR Therapeutics
PRQR
$256M
$74K 0.05%
36,280
-11,503
-24% -$23.5K
REPL icon
109
Replimune Group
REPL
$460M
$69.6K 0.05%
7,492
-9,651
-56% -$89.7K
ELDN icon
110
Eledon Pharmaceuticals
ELDN
$155M
$40.3K 0.03%
14,855
RLAY icon
111
Relay Therapeutics
RLAY
$709M
$35.6K 0.03%
10,280
-90,204
-90% -$312K
ELEV
112
DELISTED
Elevation Oncology
ELEV
$30.6K 0.02%
+83,416
New +$30.6K
ZLAB icon
113
Zai Lab
ZLAB
$3.48B
$30.5K 0.02%
+873
New +$30.5K
PRTC
114
PureTech Health
PRTC
$382M
$29.1K 0.02%
+1,685
New +$29.1K
SMMT icon
115
Summit Therapeutics
SMMT
$17.5B
$7.04K 0.01%
+331
New +$7.04K
INSM icon
116
Insmed
INSM
$30.3B
$805 ﹤0.01%
+8
New +$805
ABR icon
117
Arbor Realty Trust
ABR
$2.28B
0
ACAD icon
118
Acadia Pharmaceuticals
ACAD
$4.34B
0
AGIO icon
119
Agios Pharmaceuticals
AGIO
$2.36B
0
ALNY icon
120
Alnylam Pharmaceuticals
ALNY
$58.6B
-3,034
Closed -$819K
ALT icon
121
Altimmune
ALT
$325M
0
ANAB icon
122
AnaptysBio
ANAB
$630M
0
ASND icon
123
Ascendis Pharma
ASND
$12.1B
-1,906
Closed -$297K
JBIO
124
Jade Biosciences, Inc. Common Stock
JBIO
$245M
0
BBIO icon
125
BridgeBio Pharma
BBIO
$9.91B
0